Details for New Drug Application (NDA): 020137
✉ Email this page to a colleague
The generic ingredient in DEMADEX is torsemide. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the torsemide profile page.
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20MG/2ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 23, 1993 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 23, 1993 | TE: | RLD: | Yes |
Expired US Patents for NDA 020137
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | 4,018,929 | ⤷ Subscribe |
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | RE34672 | ⤷ Subscribe |
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | RE30633 | ⤷ Subscribe |
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | 4,822,807 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription